$Inhibikase Therapeutics (IKT.US)$ $Inhibikase Therapeutics ...
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
$Inhibikase Therapeutics (IKT.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
The Company is completing 13-week pivotal toxicology studies to be submitted to the FDA for review in August.
CEO excised options
$CohBar (CWBR.US)$
$CohBar (CWBR.US)$
..........................................
$Fulcrum Therapeutics (FULC.US)$
$Fulcrum Therapeutics (FULC.US)$
$Fulcrum Therapeutics (FULC.US)$
🚀🚀🚀🚀🚀🚀🚀🚀
$Nautilus Biotechnology (NAUT.US)$
$Bit Digital (BTBT.US)$
$NeuroMetrix (NURO.US)$
$Chembio Diagnostics (CEMI.US)$
$Starboard Value Acquisition Corp (SVAC.US)$
$Paysafe (PSFE.US)$
$NeuroMetrix (NURO.US)$
$GlaxoSmithKline (GSK.US)$
$Chembio Diagnostics (CEMI.US)$
$IGC Pharma (IGC.US)$
$Paysafe (PSFE.US)$
$QELL ACQUISITION CORP (QELL.US)$
$Bridgetown Holdings (BTWN.US)$
$SNDL Inc (SNDL.US)$
$NeuroMetrix (NURO.US)$
$Nokia Oyj (NOK.US)$
$Starboard Value Acquisition Corp (SVAC.US)$
$Bridgetown Holdings (BTWN.US)$
$Pharming Group (PHAR.US)$
$EZGO Technologies (EZGO.US)$
$Xenetic Biosciences (XBIO.US)$
$Score Media and Gaming (SCR.US)$
$Zymergen (ZY.US)$
$BlackBerry (BB.US)$
$SiTime (SITM.US)$
$Astra Space (ASTR.US)$
$Ampio Pharmaceuticals (AMPE.US)$
$Bit Digital (BTBT.US)$
$Bit Digital (BTBT.US)$
$Bit Digital (BTBT.US)$
$NeuroMetrix (NURO.US)$
$Chembio Diagnostics (CEMI.US)$
$Starboard Value Acquisition Corp (SVAC.US)$
$Paysafe (PSFE.US)$
$NeuroMetrix (NURO.US)$
$GlaxoSmithKline (GSK.US)$
$Chembio Diagnostics (CEMI.US)$
$IGC Pharma (IGC.US)$
$Paysafe (PSFE.US)$
$QELL ACQUISITION CORP (QELL.US)$
$Bridgetown Holdings (BTWN.US)$
$SNDL Inc (SNDL.US)$
$NeuroMetrix (NURO.US)$
$Nokia Oyj (NOK.US)$
$Starboard Value Acquisition Corp (SVAC.US)$
$Bridgetown Holdings (BTWN.US)$
$Pharming Group (PHAR.US)$
$EZGO Technologies (EZGO.US)$
$Xenetic Biosciences (XBIO.US)$
$Score Media and Gaming (SCR.US)$
$Zymergen (ZY.US)$
$BlackBerry (BB.US)$
$SiTime (SITM.US)$
$Astra Space (ASTR.US)$
$Ampio Pharmaceuticals (AMPE.US)$
$Bit Digital (BTBT.US)$
$Bit Digital (BTBT.US)$
kepos capital bought 700,000 shares, bull soon🐂🐂
Ex–Goldman Sachs
Quant Mark Carhart Is
Launching A New Firm
Quant Mark Carhart Is
Launching A New Firm
By launching Kepos Capital, Carhart aims to prove that quantitative global macro is stronger than ever.
$Goldman Sachs (GS.US)$
$Goldman Sachs (GS.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
supastarcwet23 : we keep thinking black rock is good under your stock..those are the same people shorting under every stock and I've notice their name comes up with a lot of manipulation stocks..crazy man